Clinical Trials

Phase II study of front line therapy with nivolumab and salvage nivolumab + ipilimumab in patients with advanced renal cell carcinoma


Study ID
Hoosier CRN GU16-260

NCT Number
NCT03117309 (Click on the NCT number for more information about the trial)

Research Study Number
2017-0601

Principle Investigator
Dr. Robert Alter

Phase
II

Sponsor
Hoosier Cancer Research Network


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now